Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1997 Feb;52(2):130–135. doi: 10.1136/thx.52.2.130

Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease

L Burdet, B de Muralt, Y Schutz, J W Fitting
PMCID: PMC1758494  PMID: 9059472

Abstract

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) are frequently malnourished and have increased resting energy expenditure (REE). An increase in the work of breathing is generally considered to be the main cause of this hypermetabolism, but other factors may also be implicated. Bronchodilators may decrease the work of breathing by reducing airway obstruction, but beta 2 adrenergic agents have a thermogenic effect. The aim of this study was to determine the effect of salbutamol and ipratropium bromide administration on REE in patients with COPD. METHODS: Thirteen patients (10 men) of mean (SD) age 68.3 (7.3) years and forced expiratory volume in one second (FEV1) 39.0 (17.0)% predicted were studied on three consecutive days. The REE was measured by indirect calorimetry at 30, 60, 120, and 180 minutes after double blind nebulisation of either salbutamol, ipratropium bromide, or placebo in random order. RESULTS: FEV1 increased both after salbutamol and after ipratropium. The difference in the mean response between salbutamol and placebo over 180 minutes was +199 ml (95% CI +104 to +295). The difference in mean response between ipratropium and placebo was +78 ml (95% CI +2 to +160). REE increased after salbutamol but was not changed after ipratropium. The difference in mean response between salbutamol and placebo was +4.8% of baseline REE (95% CI +2.2 to +7.4). Heart rate increased after salbutamol but not after ipratropium. The difference in the mean response between salbutamol and placebo was +5.5 beats/ min (95% CI +2.6 to +8.4). CONCLUSION: Salbutamol, but not ipratropium bromide, induces a sustained increase in the REE of patients with COPD despite a reduction in airway obstruction. 




Full Text

The Full Text of this article is available as a PDF (152.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amoroso P., Wilson S. R., Moxham J., Ponte J. Acute effects of inhaled salbutamol on the metabolic rate of normal subjects. Thorax. 1993 Sep;48(9):882–885. doi: 10.1136/thx.48.9.882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnes D., Delaney J. C. A comparison of salbutamol and ipratropium in chronic bronchitis and chronic airflow limitation. Br J Clin Pract. 1988 Sep;42(9):372–376. [PubMed] [Google Scholar]
  3. Blaak E. E., van Baak M. A., Kempen K. P., Saris W. H. Role of alpha- and beta-adrenoceptors in sympathetically mediated thermogenesis. Am J Physiol. 1993 Jan;264(1 Pt 1):E11–E17. doi: 10.1152/ajpendo.1993.264.1.E11. [DOI] [PubMed] [Google Scholar]
  4. Chan C. S., Brown I. G., Kelly C. A., Dent A. G., Zimmerman P. V. Bronchodilator responses to nebulised ipratropium and salbutamol singly and in combination in chronic bronchitis. Br J Clin Pharmacol. 1984 Jan;17(1):103–105. doi: 10.1111/j.1365-2125.1984.tb05008.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dash A., Agrawal A., Venkat N., Moxham J., Ponte J. Effect of oral theophylline on resting energy expenditure in normal volunteers. Thorax. 1994 Nov;49(11):1116–1120. doi: 10.1136/thx.49.11.1116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Donahoe M., Rogers R. M., Wilson D. O., Pennock B. E. Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989 Aug;140(2):385–391. doi: 10.1164/ajrccm/140.2.385. [DOI] [PubMed] [Google Scholar]
  7. Fitting J. W., Frascarolo P., Jéquier E., Leuenberger P. Energy expenditure and rib cage-abdominal motion in chronic obstructive pulmonary disease. Eur Respir J. 1989 Oct;2(9):840–845. [PubMed] [Google Scholar]
  8. Goldstein S. A., Thomashow B. M., Kvetan V., Askanazi J., Kinney J. M., Elwyn D. H. Nitrogen and energy relationships in malnourished patients with emphysema. Am Rev Respir Dis. 1988 Sep;138(3):636–644. doi: 10.1164/ajrccm/138.3.636. [DOI] [PubMed] [Google Scholar]
  9. Hugli O., Frascarolo P., Schutz Y., Jéquier E., Leuenberger P., Fitting J. W. Diet-induced thermogenesis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1479–1483. doi: 10.1164/ajrccm/148.6_Pt_1.1479. [DOI] [PubMed] [Google Scholar]
  10. Lanigan C., Moxham J., Ponte J. Effect of chronic airflow limitation on resting oxygen consumption. Thorax. 1990 May;45(5):388–390. doi: 10.1136/thx.45.5.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Motulsky H. J., Insel P. A. Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations. N Engl J Med. 1982 Jul 1;307(1):18–29. doi: 10.1056/NEJM198207013070104. [DOI] [PubMed] [Google Scholar]
  12. Muers M. F., Green J. H. Weight loss in chronic obstructive pulmonary disease. Eur Respir J. 1993 May;6(5):729–734. [PubMed] [Google Scholar]
  13. Scheidegger K., O'Connell M., Robbins D. C., Danforth E., Jr Effects of chronic beta-receptor stimulation on sympathetic nervous system activity, energy expenditure, and thyroid hormones. J Clin Endocrinol Metab. 1984 May;58(5):895–903. doi: 10.1210/jcem-58-5-895. [DOI] [PubMed] [Google Scholar]
  14. Schols A. M., Soeters P. B., Mostert R., Saris W. H., Wouters E. F. Energy balance in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991 Jun;143(6):1248–1252. doi: 10.1164/ajrccm/143.6.1248. [DOI] [PubMed] [Google Scholar]
  15. Vaisman N., Levy L. D., Pencharz P. B., Tan Y. K., Soldin S. J., Canny G. J., Hahn E. Effect of salbutamol on resting energy expenditure in patients with cystic fibrosis. J Pediatr. 1987 Jul;111(1):137–139. doi: 10.1016/s0022-3476(87)80363-3. [DOI] [PubMed] [Google Scholar]
  16. Wilson D. O., Rogers R. M., Hoffman R. M. Nutrition and chronic lung disease. Am Rev Respir Dis. 1985 Dec;132(6):1347–1365. doi: 10.1164/arrd.1985.132.6.1347. [DOI] [PubMed] [Google Scholar]
  17. Wilson D. O., Rogers R. M., Wright E. C., Anthonisen N. R. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis. 1989 Jun;139(6):1435–1438. doi: 10.1164/ajrccm/139.6.1435. [DOI] [PubMed] [Google Scholar]
  18. Wilson S. R., Amoroso P., Moxham J., Ponte J. Modification of the thermogenic effect of acutely inhaled salbutamol by chronic inhalation in normal subjects. Thorax. 1993 Sep;48(9):886–889. doi: 10.1136/thx.48.9.886. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES